Om Prakesh Yadava and Marc Ruel discuss minimally invasive cardiac surgery and the MIST trial, which is the first randomized controlled trial comparing a minimally invasive approach with sternotomy for coronary artery disease.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
May 29, 2018
May 24, 2018
Rune Haaverstad of Bergen University Hospital in Norway discusses transit-time flowmetry in CABG.
May 23, 2018
Over 1200 patients with stable coronary artery disease and at least one angiographically-significant stenosis were randomized to percutaneous coronary intervention (PCI) plus medical therapy or medical therapy alone for lesions with fractional flow reserve (FFR) <0.8. FFR-guided PCI was associated with a significantly reduced composite outcome (d
May 11, 2018
Patient Care
May 9, 2018
Shroyer and colleagues evaluated observed-to-expected outcome ratios for 30-day operative mortality and major morbidity across over 540,000 nonemergent first-time coronary artery bypass graft (CABG) procedures in The Society for Thoracic Surgeons Adult Cardiac Surgery Database.
May 4, 2018
A detailed well-referenced update on cardiovascular biomarkers, included in a compendium issue of the periodical.
May 2, 2018
Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Stan Antonides moderates a discussion with David Taggart, Joseph Sabik, and Michael Mack on improving the patency and longevity of vein grafts.
May 1, 2018
The authors performed a patient-level meta-analysis of six randomized trials comparing left internal mammary artery (LIMA) + saphenous vein graft (SVG) versus LIMA + radial artery graft.
April 27, 2018
Patient Care
April 24, 2018
The authors report on a randomized, multicenter, open-label, clinical trial involving 500 patients with 1460 saphenous vein grafts (SVG) who were assigned to three groups: (1) ticagrelor + asprin (ASA), (2) ticagrelor alone, or (3) ASA alone. Neither patients nor physicians were blinded to the allocation. The primary outcome was SVG patency at one